Abstract
P519. Efficacy and safety of biosimilar of infliximab (Inflectra) in adult patients with Crohn’s disease during 1 year of treatment, followed 6 months of observation: a one-centre retrospective study
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
